TELESTA THERAPEUTICS INC T.TST

MCNA, Urocidin, Oncocidin, Immunocidin, Olds' Note

[RetailRube]

I'm still confused.

I wanted Telesta to retain rights to the human application for the drug which seems to help rapidly restore normal blood balance following chemotherapy.  I recall someone saying it accelerates the reduction in white blood cell count, helping speed recovery from a chemo session.  This sounds like a potential blockbuster opportunity in humans.

Mr. Olds' note tells us that MCNA applied to animal health is called Oncocidin.

So has Telesta retained all rights to the human application to reduce white blood cell count after chemo?

[account15]

Also why trademark that belongs to Nova includes human as well as animal classification. Should it exclude human treatment as per email response? I also believe that oncocidin was immune boost after chemo. And was different from MCNA platform or is it MCNA platform only administered under different method.? Please help.

[RetailRube]

Trademarks don't control rights to make and sell a product.  Patent licencing does.  So if the trademark now misrepresents the product's application scope after the various corporate transfers then the current owner could file an update with the trademark registry offices to correct the description.  Eventually.

[Frogger2]

That clears that up, thanks Rube. It sure would be nice if they don't take the full twenty days remaining to file. It would also be a great time to over deliver with some news around their future plans.

[somweyungguy]

Frog, Yur up early chief.....are you strok'n RetailRub as part of yur breakfast program?  Frog do you happen to jump"over the lake only" I'm still waiting to here how long it's been since they completed their first and only pahse III trial, you know the one they're basing their BLA submission on.  I don't want it expalined in terms of additional shares